ARCEX® is our investigational, external, non-invasive spinal cord stimulation system designed to improve upper extremity strength, function, and other symptoms in people with SCI.
Read The Evidence
The results from our Up-LIFT pivotal trial were published in Nature Medicine, one of the world’s preeminent scientific journals.
The Up-LIFT study evaluated the safety and effectiveness of non-invasive electrical spinal cord stimulation (ARCEX Therapy) to improve upper limb mobility in people with chronic incomplete tetraplegia. The clinical study enrolled 65 people at 14 leading SCI centers in the US, Europe, and Canada.
Highlights* include:
Primary safety and effectiveness endpoints met.
90% of participants improved strength or function of their upper limbs.
87% of participants reported improvement in quality of life.
Improvement was demonstrated in participants up to 34 years post-injury.
Discover The Potential Benefits
ARCEX is designed to help people with spinal cord injury regain more control over their day.
The system consists of an external Stimulator and electrodes designed specifically for people with SCI.
Discover The Potential Benefits
ARCEX is designed to help people with spinal cord injury regain more control over their day.
The system consists of an external Stimulator and electrodes designed specifically for people with SCI.
Arm and hand movement
Dexterity and finger control
Sensation
“When we talk about 10% more function, we think about how important that is in terms of being able to live a life. That little bit more independence allows you to do so much more.”
Jessie Owen
ARCEX Therapy trial participant
Stay Updated
As of April, 2024, we have submitted a regulatory application to the US Food and Drug Administration (FDA) to allow marketing of our breakthrough ARCEX System to restore function of the upper extremities after spinal cord injury.
Contact Us
Please fill out the form
if you would like to contact
us or receive updates
All ONWARD® Medical devices and therapies referenced here, including but not limited to ARCIM®, ARCEX®, ARCBCI™, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.
*Moritz, Chet, et al. “Non-invasive spinal cord stimulation for arm and hand function in chronic tetraplegia: a safety and efficacy trial.” Nature Medicine. 2024.